NOVEL GADOLINIUM-BASED COMPOUND, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE COMPRISING THE SAME, AND MRI CONTRAST COMPOSITION

摘要

The present invention relates to a gadolinium-based compound represented by the following formula (1). [Formula 1] In Formula 1, RosA is a moiety derived from rosmarinic acid. The compound according to the present invention may be used in a composition for treating or preventing an inflammatory disease and/or an MRI contrast composition for diagnosing an inflammatory disease or a degenerative brain disease.